These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10505549)

  • 21. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.
    Vlems FA; Diepstra JH; Cornelissen IM; Ruers TJ; Ligtenberg MJ; Punt CJ; van Krieken JH; Wobbes T; van Muijen GN
    Mol Pathol; 2002 Jun; 55(3):156-63. PubMed ID: 12032226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new approach for discovering minimal residual disease in patients with operable breast cancer].
    Iovchev I; Trifonov D; Nikolov S; Lazarov N; Dimitrov G
    Khirurgiia (Sofiia); 2003; 59(3):19-22. PubMed ID: 15584457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.
    Braun S; Rosenberg R; Thorban S; Harbeck N
    Semin Surg Oncol; 2001 Jun; 20(4):334-46. PubMed ID: 11747276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Micrometastases in pediatric oncology].
    Bernard F; Aerts I; Margueritte G; Astruc J
    Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination.
    Ballestrero A; Coviello DA; Garuti A; Nencioni A; Famà A; Rocco I; Bertorelli R; Ferrando F; Gonella R; Patrone F
    Cancer; 2001 Oct; 92(8):2030-5. PubMed ID: 11596016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Researchers exploring implications of minimal residual cancer.
    McBride G
    J Natl Cancer Inst; 2005 Nov; 97(22):1642-3. PubMed ID: 16288116
    [No Abstract]   [Full Text] [Related]  

  • 30. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technical aspects of minimal residual disease detection in carcinoma patients.
    Lacroix J; Doeberitz MK
    Semin Surg Oncol; 2001 Jun; 20(4):252-64. PubMed ID: 11747266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
    Kienle P; Weitz J; Klaes R; Koch M; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Arch Surg; 2000 Feb; 135(2):213-8. PubMed ID: 10668884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult metastases in patients with breast cancer.
    Hawes D; Neville AM; Cote RJ
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):60S-63S. PubMed ID: 11599903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR.
    Berois N; Varangot M; Aizen B; Estrugo R; Zarantonelli L; Fernández P; Krygier G; Simonet F; Barrios E; Musé I; Osinaga E
    Eur J Cancer; 2000 Apr; 36(6):717-23. PubMed ID: 10762743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
    Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
    Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer.
    Cooper BW; Moss TJ; Ross AA; Ybanez J; Lazarus HM
    J Clin Oncol; 1998 Nov; 16(11):3509-17. PubMed ID: 9817268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular detection of micrometastatic breast cancer.
    Baker M; Gillanders WE; Mikhitarian K; Mitas M; Cole DJ
    Am J Surg; 2003 Oct; 186(4):351-8. PubMed ID: 14553849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood.
    Zhong XY; Kaul S; Thompson J; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):669-74. PubMed ID: 10592099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.